Applications of (S)-(-)-1-Boc-2-Pyrrolidinemethanol in Industrial Manufacturing

(S)-(-)-1-Boc-2-Pyrrolidinemethanol is a valued chiral intermediate widely integrated by pharmaceutical and specialty chemical manufacturers. Its defined stereochemistry and protecting group compatibility ensure precise downstream synthesis in dedicated industrial sectors. As an original producer, we supply high-purity grades targeting established application fields where quality consistency and trackability drive end-product reliability.

1. Active Pharmaceutical Ingredient (API) Synthesis for CNS Drug Manufacturing

Manufacturers of central nervous system (CNS) modulators utilize this intermediate as a key building block during the synthesis of enantiomerically pure API cores. Its precisely protected amine group delivers reactivity control during coupling and cyclization routes, streamlining multi-step synthetic campaigns for cognitive disorder therapies and psychotropic agents.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• US FDA 21 CFR Part 211 (Current Good Manufacturing Practice for Finished Pharmaceuticals)
• European Pharmacopoeia 11.0 (Stereoisomeric Purity)
• Japanese Pharmacopoeia General Rules for Preparations

Typical usage ratio

• 10–35 mol% relative to the target API synthetic pathway, dependent on route yield, desired enantiomeric excess, and scale-up requirements

Downstream process integration

• Introduced after initial backbone assembly for chiral center installation; deprotection and further derivatization proceed post-coupling
• Incorporated as an intermediate during asymmetric synthesis before final API formation and crystallization

Final product types

• Chiral pyrrolidine-based CNS APIs (e.g., nootropics, antipsychotics, anticonvulsants)
• Intermediates for regulatory-submitted finished dosage forms

2. Chiral Catalyst Ligand Precursor Production (Fine Chemical Manufacturing)

Producers of asymmetric catalysts select (S)-(-)-1-Boc-2-Pyrrolidinemethanol for constructing chiral ligands essential to enantioselective hydrogenation and addition reactions. The molecule’s protected amine and secondary alcohol functionalities allow for versatile derivatization, supporting both academic and industrial process catalyst innovation.

Industry compliance standards

• ISO 9001:2015 (Quality Management Systems for Fine Chemicals)
• REACH Regulation (EC) No 1907/2006 (Substance Registration for EU Markets)
• Responsible Care® Management Systems (Chemical Handling & Safety)
• In-house specifications for trace metal and optical purity

Typical usage ratio

• 5–25% of total ligand backbone feed, dependent on catalyst design and productivity targets for the end-user application

Downstream process integration

• Block enters in the ligand pre-synthesis stage, followed by deprotection or cross-coupling to introduce advanced stereodefined groups
• Processed in pilot and production-scale catalyst synthesis suites with chiral HPLC downstream quality monitoring

Final product types

• Chiral phosphine or amine ligands for industrial asymmetric hydrogenation catalysts
• Proprietary catalyst systems used in fine chemical and API manufacturing

3. Synthesis of Specialty Agrochemical Intermediates

Agrochemical manufacturers employ this chiral intermediate to develop enantiomerically defined precursors for selective pesticide and plant growth regulator molecules. The presence of a removable Boc group offers strategic flexibility in constructing target molecules exhibiting crop-selective bioactivity.

Industry compliance standards

• FAO/WHO Guidelines for the Quality Control of Pesticides
• ISO 17025:2017 (Analytical Laboratory Certification)
• REACH Regulation (EC) No 1907/2006
• Hazardous Substances Certification (GHS labeling and SDS conformity)

Typical usage ratio

• 5–15% on a molar basis, optimized during structure-activity relationship (SAR) screening and pre-commercial scale-up

Downstream process integration

• Integration after lead discovery, typically as a late-stage intermediate prior to functional group elaboration and ring closure
• Deprotection and further transformation processed in batch or semi-continuous synthesis lines

Final product types

• Enantiomer-enriched crop protection agents
• Herbicide and insecticide intermediates requiring stringent chiral purity for regulatory dossiers

4. Custom Peptide and Peptidomimetic Synthesis (Contract Manufacturing & Research)

Custom peptide synthesis companies and CDMOs leverage this intermediate to introduce stereodefined pyrrolidine residues and functionalized side chains in peptide and peptidomimetic frameworks. The Boc protection ensures stepwise solid-phase or solution-phase assembly without premature amine exposure, supporting complex sequence construction.

Industry compliance standards

• ICH Q11 (Development and Manufacture of Drug Substances); applicable to peptide APIs
• US Pharmacopeia (USP) <1047> DNA-based and Peptide-based Drugs
• ISO 13485:2016 (Quality Systems in Peptide-Based Medical Devices)
• GMP Guidelines for Oligonucleotide and Peptide Synthesis

Typical usage ratio

• Varies by target sequence: 1 equivalent for single residue incorporation, up to 20% of total protected amino acid mixture for multi-residue peptidomimetics

Downstream process integration

• Added after resin loading or as a solution-phase coupling partner before global deprotection and purification
• Employed in combinatorial libraries to expand conformational diversity of produced peptides

Final product types

• Therapeutic peptides with defined chiral centers (e.g., peptide hormone analogs)
• Functionalized peptide building blocks for research applications